• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

European Pharmaceutical Review Extra

The latest blogs, views and comments on the Pharma world from the leading experts in the industry…

If you would like to submit an article for the website, contact Victoria White.


Hepatitis C

Hepatitis C: commitment to a cure

Posted on: 28 July 2016 | Author: Niamh Louise Marriott, Digital Content Producer

To find out more about Hepititis C, European Pharmaceutical Review spoke with Raquel Peck, CEO of the World Hepatitis Alliance and discovered exactly what it is being done to combat this widespread global health issue...


Celltrion Healthcare on Remsima and biosimilars

Posted on: 15 July 2016 | Author: European Pharmaceutical Review

With Remsima being on the market for a year, European Pharmaceutical Review caught up with Celltrion Healthcare to find out more about biosimilars...

cystic fibrosis

Exploring the need for mutation-specific treatments in cystic fibrosis

Posted on: 1 July 2016 | Author: Caroline Richards, Editor, European Pharmaceutical Review

Here, Caroline Richards, Editor of European Pharmaceutical Review, discusses cystic fibrosis and the treatment options that are currently available or in development...

eu referendum

EU Referendum: Tell us what you think…

Posted on: 20 June 2016 | Author: Caroline Richards, Editor, European Pharmaceutical Review

With only days to go until Britain holds a referendum on its EU membership, we can't help but wonder how you feel...


Growth remedy: Accelerating drug performance by prioritising patient opportunities

Posted on: 13 June 2016 | Author: Joaquim Nascimento

In this article, Joaquim Nascimento discusses a three-step process to identify and prioritise initiatives to improve drug sales...

eu referendum

Leaving EU could be a setback for Life Sciences in the UK

Posted on: 8 June 2016 | Author: Dr Alexander Moscho, Bayer UK & Ireland CEO

In this opinion piece, Dr Alexander Moscho, Bayer UK & Ireland CEO, says a vote to leave the EU will deter investment and make it harder for patients to access new medicines...

boehringer ingelheim

Boehringer Ingelheim at ASCO: Oncology and Innovation

Posted on: 6 June 2016 | Author: Victoria White, Digital Content Producer

We recently caught up with Dr Jörg Barth, Boehringer Ingelheim, to find out more about the company’s oncology pipeline and presence at ASCO....


Soligenix on IDR technology and SGX942

Posted on: 10 May 2016 | Author: Victoria White, Digital Content Producer

We discuss Innate Defense Regulator (IDR) technology with Soligenix's Chief Scientific Officer, Dr Oreola Donini, and find out more about SGX942...

Prader-Willi Syndrome

AZP-531 and its potential in Prader-Willi Syndrome

Posted on: 9 May 2016 | Author: Victoria White, Digital Content Producer

In this exclusive interview, Thierry Abribat, president of Alizé Pharma, discusses AZP-531 and its potential as a treatment for Prader-Willi Syndrome...


From HIV to oncology: widening access through flexible IP

Posted on: 28 April 2016 | Author: Jon Pender, VP Government Affairs, GSK

Jon Pender, GSK, discusses how a flexible and thoughtful approach to IP can help get medicines to the poorest and hardest-to-reach patients around the world...


The threat of antibiotic resistance

Posted on: 27 April 2016 | Author: Victoria White, Digital Content Producer

We've created an infographic on the threat of antibiotic resistance, highlighting some of the recommendations made by the Review on AMR...

Proteomic Mass Spectrometry

Proteomic mass spectrometry imaging for detecting malignant melanoma

Posted on: 26 April 2016 | Author: Victoria White, Digital Content Producer

In an exclusive interview, Erin Seeley of Protea Biosciences discusses Proteomic Mass Spectrometry Imaging and Protea's recently announced license agreement with Yale...


Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +